Filter results

Pharmaceutical Reports

By Geography
By Sector
By Publication Type
Showing
81-100 of 179
Mexico Pharmaceuticals & Healthcare Report

Mexico Pharmaceuticals & Healthcare Report

BMI View: Mexico's pharmaceutical market will continue to pose significant challenges for drugmakers. Increasing cost-containment measures will repress patented medicine growth , while generic substitution will become more prominent as the burden of chronic diseases ...
$1,375.00
Read More
Middle East And North Africa Pharmaceuticals & Healthcare Report

Middle East And North Africa Pharmaceuticals & Healthcare Report

BMI View : The Middle East and North Africa (MENA) pharmaceuticals market will remain a key opportunity for drugmakers in the region, yet will continue to face headwinds that challenge growth. The near-term picture remains uncertain, ...
$1,375.00
Read More
Moldova Pharmaceuticals & Healthcare Report

Moldova Pharmaceuticals & Healthcare Report

BMI View: Drugmakers will continue to see Moldova as an unattractive market for investment. Medicine sales growth potential is inferior to many of its emerging market neighbours. Moreover, high levels of industry- and country-specific risks, ...
$1,375.00
Read More
Morocco Pharmaceuticals & Healthcare Report

Morocco Pharmaceuticals & Healthcare Report

BMI View: The Moroccan pharmaceutical market will continue to be held back by the country's low purchasing power and small pensionable population , which limits demand for high-value chronic disease treatments. The government's commitment ...
$1,375.00
Read More
Mozambique Pharmaceuticals & Healthcare Report

Mozambique Pharmaceuticals & Healthcare Report

BMI View: Mozambique's pharmaceutical market is severely underdeveloped by both global and regional standards. Although such underdevelopment, coupled with the country's high disease burden and rapidly growing population, has the potential to give ...
$1,375.00
Read More
Myanmar Pharmaceuticals & Healthcare Report

Myanmar Pharmaceuticals & Healthcare Report

BMI View: The combination of major reforms to Myanmar's IP laws - which are to be promulgated by the end of 2017 - and FDI regulations to allow medicine production and private hospital construction to ...
$1,375.00
Read More
Namibia Pharmaceuticals & Healthcare Report

Namibia Pharmaceuticals & Healthcare Report

BMI View: Namibian manufacturing capabilities are small, predominantly focusing on the production of generic medicines, although these face increasing competition from Indian companies. Despite a relatively attractive business environment, multinational drugmakers will continue to use ...
$1,375.00
Read More
Netherlands Pharmaceuticals & Healthcare Report

Netherlands Pharmaceuticals & Healthcare Report

BMI View: Netherlands pharmaceutical market is expected to return to growth in 2017, albeit marginally, following five years of decline. Medicine sales will remain modest in the coming years driven by an ageing population and rising ...
$1,375.00
Read More
New Zealand Pharmaceuticals & Healthcare Report

New Zealand Pharmaceuticals & Healthcare Report

BMI View: New Zealand's pharmaceutical and healthcare markets continue to draw interest from innovative drugmakers, given factors such as the high level of care and also of chronic disease burden. However, the operating envi ...
$1,375.00
Read More
Nicaragua Pharmaceuticals & Healthcare Report

Nicaragua Pharmaceuticals & Healthcare Report

BMI View: The pharmaceutical market in Nicaragua will continue to experience strong growth in the coming years. The demand for medicine will be driven by improvements in healthcare services, supported by government investments. However, multinational ...
$1,375.00
Read More
Nigeria Pharmaceuticals & Healthcare Report

Nigeria Pharmaceuticals & Healthcare Report

BMI View : The Nigerian pharmaceutical and healthcare industry is underdeveloped by global standards and remains heavily dependent on imports to supply inputs for manufacturing and to meet the local medicine demand. We expect that domestic ...
$1,375.00
Read More
Norway Pharmaceuticals & Healthcare Report

Norway Pharmaceuticals & Healthcare Report

BMI View: Norway's pharmaceutical market will continue to post an above-average growth rate in Western Europe, albeit from a small base by regional standards, over the forecast period. High spending per capita on medicine ...
$1,375.00
Read More
Oman Pharmaceuticals & Healthcare Report

Oman Pharmaceuticals & Healthcare Report

BMI View: Challenging fiscal conditions in Oman continue to drive cost containment measures in the public provision of pharmaceuticals and healthcare services . P hased pharmaceutical price reductions pose near - term risks for manufacturers and ...
$1,375.00
Read More
Pakistan Pharmaceuticals & Healthcare Report

Pakistan Pharmaceuticals & Healthcare Report

BMI View: Low affordability levels and nascent regulatory environment will continue to dictate a tailored multinational company strategy in Pakistan. Nevertheless, the rising chronic disease burden, combined with government incentives to improve access to treatment, ...
$1,375.00
Read More
Panama Pharmaceuticals & Healthcare Report

Panama Pharmaceuticals & Healthcare Report

BMI View: Panama's pharmaceutical and healthcare market will continue to expand over the forecast period, albeit from a low base compared with larger markets in the Americas region. Gradual improvements in the health system ...
$1,375.00
Read More
Peru Pharmaceuticals & Healthcare Report

Peru Pharmaceuticals & Healthcare Report

BMI View: Political tensions and inter-party conflict will be reignited as result of both President Kuczysnki and opposition leader Keiko Fujimori being implicated in the Odebrecht graft scandal. This could derail recent legislative progress between ...
$1,375.00
Read More
Philippines Pharmaceuticals & Healthcare Report

Philippines Pharmaceuticals & Healthcare Report

BMI View: Expansion of PhilHealth coverage, with the aim of achieving universal coverage, will continue to be an important driver of pharmaceuticals and healthcare market growth. While the country's disease profile will continue to ...
$1,375.00
Read More
Poland Pharmaceuticals & Healthcare Report

Poland Pharmaceuticals & Healthcare Report

BMI View: The government continues to be active in reform of the pharmaceutical and healthcare markets, focussed on increasing access to and affordability of treatments. Over the short term, changes to reimbursement and co-payment exemptions ...
$1,375.00
Read More
Portugal Pharmaceuticals & Healthcare Report

Portugal Pharmaceuticals & Healthcare Report

BMI View: The Portuguese pharmaceutical market will continue to show signs of strength, translating into improved commercial opportunities for drugmakers over the next few quarters. On the back of a more robust economic recovery, the ...
$1,375.00
Read More
Puerto Rico Pharmaceuticals & Healthcare Report

Puerto Rico Pharmaceuticals & Healthcare Report

BMI View: While fiscal consolidation efforts will be partially postponed due to severe damages caused by hurricanes Irma and Maria, Puerto Rico's long-term healthcare and fiscal outlooks remain broadly unchanged. Meanwhile, the gradual reparation ...
$1,375.00
Read More
Showing
81-100 of 179